Eric Schadt is Mount Sinai Professor in Predictive Health and Computational Biology at the Icahn School of Medicine in New York City. He is also founder and chief executive officer of the predictive health company Sema4.
Eric Schadt
Professor
Icahn School of Medicine at Mount Sinai
From this contributor
Counseling can ease shock of unexpected genetic results
The best way to deliver surprises from genetic findings is to provide adequate information and counseling alongside the results.
Counseling can ease shock of unexpected genetic results
Explore more from The Transmitter
Unconfounding genetic and environmental factors, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 31 August.
Unconfounding genetic and environmental factors, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 31 August.
Amid funding uncertainty, neuroscientists report a mix of cynicism, persistence
Two years into one of the most tumultuous tenures in U.S. federal funding, researchers outline how they are coping with ongoing changes and reflect on the impact these changes are having on the system more broadly.
Amid funding uncertainty, neuroscientists report a mix of cynicism, persistence
Two years into one of the most tumultuous tenures in U.S. federal funding, researchers outline how they are coping with ongoing changes and reflect on the impact these changes are having on the system more broadly.
Reimagining Mexico’s brain bank
Since Alzheimer’s disease researcher José Luna-Muñoz assumed leadership of the facility—Latin America’s oldest—in 2011, he has been acquiring additional tissue types and is working to expand donor recruitment to rural areas.
Reimagining Mexico’s brain bank
Since Alzheimer’s disease researcher José Luna-Muñoz assumed leadership of the facility—Latin America’s oldest—in 2011, he has been acquiring additional tissue types and is working to expand donor recruitment to rural areas.